255 related articles for article (PubMed ID: 10704468)
1. CD5 maintains tolerance in anergic B cells.
Hippen KL; Tze LE; Behrens TW
J Exp Med; 2000 Mar; 191(5):883-90. PubMed ID: 10704468
[TBL] [Abstract][Full Text] [Related]
2. Anergic B cells constitutively present self antigen: enhanced immunoglobulin receptor-mediated presentation of antigenic determinants by B cells is hierarchical.
Kanost D; McCluskey J
Eur J Immunol; 1994 May; 24(5):1186-93. PubMed ID: 7514133
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen.
Brink R; Goodnow CC; Crosbie J; Adams E; Eris J; Mason DY; Hartley SB; Basten A
J Exp Med; 1992 Oct; 176(4):991-1005. PubMed ID: 1402669
[TBL] [Abstract][Full Text] [Related]
4. PECAM-1-regulated signalling thresholds control tolerance in anergic transgenic B-cells.
Wong MX; Hayball JD; Jackson DE
Mol Immunol; 2008 Mar; 45(6):1767-81. PubMed ID: 17977600
[TBL] [Abstract][Full Text] [Related]
5. B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells.
Phan TG; Amesbury M; Gardam S; Crosbie J; Hasbold J; Hodgkin PD; Basten A; Brink R
J Exp Med; 2003 Apr; 197(7):845-60. PubMed ID: 12668643
[TBL] [Abstract][Full Text] [Related]
6. Anergic self-reactive B cells present self antigen and respond normally to CD40-dependent T-cell signals but are defective in antigen-receptor-mediated functions.
Eris JM; Basten A; Brink R; Doherty K; Kehry MR; Hodgkin PD
Proc Natl Acad Sci U S A; 1994 May; 91(10):4392-6. PubMed ID: 7514304
[TBL] [Abstract][Full Text] [Related]
7. Ig light chain receptor editing in anergic B cells.
Tze LE; Baness EA; Hippen KL; Behrens TW
J Immunol; 2000 Dec; 165(12):6796-802. PubMed ID: 11120801
[TBL] [Abstract][Full Text] [Related]
8. Virus-like display of a neo-self antigen reverses B cell anergy in a B cell receptor transgenic mouse model.
Chackerian B; Durfee MR; Schiller JT
J Immunol; 2008 May; 180(9):5816-25. PubMed ID: 18424700
[TBL] [Abstract][Full Text] [Related]
9. Reduced life span of anergic self-reactive B cells in a double-transgenic model.
Fulcher DA; Basten A
J Exp Med; 1994 Jan; 179(1):125-34. PubMed ID: 8270860
[TBL] [Abstract][Full Text] [Related]
10. IL-4 promotes Stat6-dependent survival of autoreactive B cells in vivo without inducing autoantibody production.
Morris SC; Dragula NL; Finkelman FD
J Immunol; 2002 Aug; 169(4):1696-704. PubMed ID: 12165489
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen.
Swanson-Mungerson MA; Caldwell RG; Bultema R; Longnecker R
J Virol; 2005 Jun; 79(12):7355-62. PubMed ID: 15919890
[TBL] [Abstract][Full Text] [Related]
12. Modulation of peripheral B cell tolerance by CD72 in a murine model.
Li DH; Winslow MM; Cao TM; Chen AH; Davis CR; Mellins ED; Utz PJ; Crabtree GR; Parnes JR
Arthritis Rheum; 2008 Oct; 58(10):3192-204. PubMed ID: 18821699
[TBL] [Abstract][Full Text] [Related]
13. CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes.
Inaoki M; Sato S; Weintraub BC; Goodnow CC; Tedder TF
J Exp Med; 1997 Dec; 186(11):1923-31. PubMed ID: 9382890
[TBL] [Abstract][Full Text] [Related]
14. In vivo assessment of the relative contributions of deletion, anergy, and editing to B cell self-tolerance.
Hippen KL; Schram BR; Tze LE; Pape KA; Jenkins MK; Behrens TW
J Immunol; 2005 Jul; 175(2):909-16. PubMed ID: 16002689
[TBL] [Abstract][Full Text] [Related]
15. B cell expression of the SH2-containing inositol 5-phosphatase (SHIP-1) is required to establish anergy to high affinity, proteinacious autoantigens.
Akerlund J; Getahun A; Cambier JC
J Autoimmun; 2015 Aug; 62():45-54. PubMed ID: 26152931
[TBL] [Abstract][Full Text] [Related]
16. Intact B cell tolerance in the absence of the first component of the classical complement pathway.
Cutler AJ; Cornall RJ; Ferry H; Manderson AP; Botto M; Walport MJ
Eur J Immunol; 2001 Jul; 31(7):2087-93. PubMed ID: 11449362
[TBL] [Abstract][Full Text] [Related]
17. Chronic GVH prevents anergy in bone marrow self-reactive B cells: a selective increase in post-endoplasmic reticulum processing and trafficking to the cell surface of autoreactive IgM receptors.
Feuerstein N; Shivers D; Chen F; Eisenberg RA; Finkel TH
Int Immunol; 2003 Aug; 15(8):975-85. PubMed ID: 12882835
[TBL] [Abstract][Full Text] [Related]
18. Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells.
Ho WY; Cooke MP; Goodnow CC; Davis MM
J Exp Med; 1994 May; 179(5):1539-49. PubMed ID: 7909325
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells.
Cooke MP; Heath AW; Shokat KM; Zeng Y; Finkelman FD; Linsley PS; Howard M; Goodnow CC
J Exp Med; 1994 Feb; 179(2):425-38. PubMed ID: 8294858
[TBL] [Abstract][Full Text] [Related]
20. Requirement for Transcription Factor Ets1 in B Cell Tolerance to Self-Antigens.
Russell L; John S; Cullen J; Luo W; Shlomchik MJ; Garrett-Sinha LA
J Immunol; 2015 Oct; 195(8):3574-83. PubMed ID: 26355157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
